Back to search
High-Risk Nevus Phenotype
Clinical trial pipeline · Data from ClinicalTrials.gov
See which High-Risk Nevus Phenotype trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which High-Risk Nevus Phenotype trials you may qualify forThe investigators are doing this study to improve our ability to identify which people with many moles on their skin are most likely to develop skin melanoma. T…
Background: -Although IL-2 can shrink tumors in about 20 percent of patients with metastatic kidney cancer and in 15 percent of patients with metastatic melano…